The use of psychotropic medication in the management of problem behaviors in the patient with Alzheimer's disease

Med Clin North Am. 1994 Jul;78(4):811-22. doi: 10.1016/s0025-7125(16)30135-3.

Abstract

Although a variety of potential alternatives to the neuroleptics in the management of agitated behavior in Alzheimer's disease exist, more large, well-controlled studies are needed. At present, neuroleptics remain the standard treatment for this problem. It is also important for the clinician to investigate thoroughly underlying instigators of behavior change in Alzheimer's patients, such as delirium, anxiety, depression, or environmental factors, and target treatment to these disorders.

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Aged
  • Alzheimer Disease / psychology*
  • Anticonvulsants / therapeutic use
  • Benzodiazepines / therapeutic use
  • Humans
  • Lithium / therapeutic use
  • Mental Disorders / drug therapy*
  • Psychotropic Drugs / therapeutic use*
  • Serotonin Receptor Agonists / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Anticonvulsants
  • Psychotropic Drugs
  • Serotonin Receptor Agonists
  • Benzodiazepines
  • Lithium